Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
American Boston Biotechnology (ABBC) is a biotechnology company that provides a range of research and development services to the pharmaceutical and life sciences industries. The company specializes in custom peptide synthesis, antibody production, and small molecule synthesis to support drug discovery and development. ABBC operates with a focus on high-quality reagents and contract research services, catering to academic institutions and biotech firms globally. Their portfolio includes specialized chemical building blocks and catalog products used in various therapeutic research areas, including oncology and metabolic disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Boston Biotechnology.